ArticleEuropean archives of psychiatry and clinical neuroscience2010
The role of proteomics in depression research.
Article in European archives of psychiatry and clinical neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- The Role of Mitochondrial Dysfunction-Mediated Changes in Immune Cytokine Expression in the Pathophysiology and Treatment of Major Depressive Disorder.Molecular neurobiology · 2025Review
- Decoding cocaine-induced proteomic adaptations in the mouse nucleus accumbens.Science signaling · 2024Article
- An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks.Biomedicines · 2020Article
- Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders.Genes · 2020Article
- Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons.Journal of affective disorders · 2019Article
- iTRAQ-Based Quantitative Proteomics Suggests Synaptic Mitochondrial Dysfunction in the Hippocampus of Rats Susceptible to Chronic Mild Stress.Neurochemical research · 2018Article
- Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Journal of affective disorders · 2018Review
- A Clinician's Perspective on Biomarkers.Focus (American Psychiatric Publishing) · 2018Review
- Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study.Translational psychiatry · 2017Article
- Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.The international journal of neuropsychopharmacology · 2015Review
- The potential of biomarkers in psychiatry: focus on proteomics.Journal of neural transmission (Vienna, Austria : 1996) · 2015Review
- Inflammatory biomarkers as differential predictors of antidepressant response.International journal of molecular sciences · 2015Review
- Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer.Journal of pain and symptom management · 2014Article
- Plasma fibrinogen: now also an antidepressant response marker?Translational psychiatry · 2014Article
- Effects of chronic stress on prefrontal cortex transcriptome in mice displaying different genetic backgrounds.Journal of molecular neuroscience : MN · 2013Article
- Biomarkers predicting antidepressant treatment response: how can we advance the field?Disease markers · 2013Review
- Differential phosphoproteome regulation of nucleus accumbens in environmentally enriched and isolated rats in response to acute stress.PloS one · 2013Article
- Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function.European archives of psychiatry and clinical neuroscience · 2012Article
- Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.European archives of psychiatry and clinical neuroscience · 2012Article
- Depression is associated with low levels of 25-hydroxyvitamin D among Jordanian adults: results from a national population survey.European archives of psychiatry and clinical neuroscience · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is a severe neuropsychiatric disorder affecting approximately 10% of the world population. Despite this, the molecular mechanisms underlying the disorder are still not understood. Novel technologies such as proteomic-based platforms are beginning to offer new insights into this devastating illness, beyond those provided by the standard targeted methodologies. Here, we will show the potential of proteome analyses as a tool to elucidate the pathophysiological mechanisms of depression as well as the discovery of potential diagnostic, therapeutic and disease course biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.